Future developments in DNA sequencing technology and bioinformatics are expected to enhance our understanding of cancer and improve patient outcomes. Innovations such as liquid biopsy, which analyzes DNA fragments found in blood, offer non-invasive methods for early detection and monitoring of cancer.
